πŸ“‹ Medical Procedure Code

G0482

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed
Other Descriptions:
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not
DRUG TEST DEF 15-21 CLASSES
DRUG TEST DEF 15-21 CLASSES (TRIDENT)
HC DRUG TESTS DEFINITIVE PER DAY 15-21 CLASSES
Drug test def 15+AC0-21 classes
Related codes:
Code: G0480
Description: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed
HCPCS Category: Temporary procedures and professional services
Code: G0481
Description: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed
HCPCS Category: Temporary procedures and professional services
Code: G0483
Description: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed
HCPCS Category: Temporary procedures and professional services

Compare Hospital Prices Across the United States

This page shows the cost variations for procedure code G0483 across different hospitals in the United States. The data is compiled from hospital chargemaster files, which list the standard charges for medical procedures and services.

Why do prices vary? Hospital pricing can differ significantly based on location, facility type, and local market conditions. Use this data to understand price ranges and compare costs across states and hospitals.

Average
$963
Median
$597
Hospitals
341

πŸ—ΊοΈ Interactive Price Map

πŸ’‘ Tip: Click on any state to explore detailed hospital pricing. Hover to see quick statistics. Darker shades indicate higher average costs.

πŸ“Š Average Prices by State

Click on any state to view individual hospital prices and detailed breakdowns.

State Average Price Number of Hospitals
Michigan (MI) $150 59
Hawaii (HI) $175 5
New York (NY) $199 2
Oklahoma (OK) $203 3
Pennsylvania (PA) $257 3
Rhode Island (RI) $291 5
Wisconsin (WI) $307 14
North Carolina (NC) $359 13
Vermont (VT) $408 2
Washington (WA) $413 4
Utah (UT) $457 4
Mississippi (MS) $480 6
Florida (FL) $499 91
West Virginia (WV) $544 3
Kentucky (KY) $551 3
North Dakota (ND) $632 2
Georgia (GA) $661 15
South Carolina (SC) $684 3
Tennessee (TN) $760 4
Idaho (ID) $847 1
Indiana (IN) $996 14
Texas (TX) $1,265 22
Virginia (VA) $1,936 9
Nevada (NV) $2,426 6
California (CA) $2,448 26
Kansas (KS) $2,970 8
Missouri (MO) $3,602 10
Alabama (AL) $3,962 2
Colorado (CO) $17,730 2

ℹ️ About This Data

The prices shown are from hospital chargemaster files, which represent the list prices hospitals charge before insurance negotiations or discounts. Your actual cost may be different depending on your insurance coverage, deductibles, and negotiated rates. Always check with your insurance provider and hospital for accurate cost estimates.


ChargemasterDB by Joseph Paul Cohen
A database of US hospital prices based on data made available by the Centers for Medicare & Medicaid Services (CMS), HHS price transparancy rule 45 CFR Β§180.